Urihk Pharmaceuticals
  • Home
  • About Us
    • Our Team
    • The Urihk Partnership
  • Products
    • Antibiotic
    • Antifungal
    • Antioxidant
    • Immuno modulator
    • Neuro/CNS
  • Services
  • Learn More
    • News
    • Gallery
    • Careers
  • Contact Us
Select Page
Back
Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B
Oct 26, 2021

Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
Oct 26, 2021

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection

Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms
Oct 26, 2021

Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms

Antibiotic Sensitivity Pattern of Gram-Negative Bacilli Isolated from the Lower Respiratory Tract of Ventilated Patients in the Intensive Care Unit
Oct 26, 2021

Antibiotic Sensitivity Pattern of Gram-Negative Bacilli Isolated from the Lower Respiratory Tract of Ventilated Patients in the Intensive Care Unit

ABOUT URIHK

URIHK pharmaceuticals is a wholly owned subsidiary of UREKA Hong Kong Ltd. We are a vertically integrated pharmaceutical company that launches, registers and distributes innovative products in India.
 

SITEMAP

About Us

Services

Products

Careers

Privacy Policy

CONTACT US

602-603, Sai Samarth Business Park,
Deonar, Govandi (East),
Mumbai (400088), India
Phone: +91 22 497 01103 / 43286
Email: [email protected]